Meningitis C

Study highlights success of vaccination program among U.K. children

Published in TB and Outbreaks Week, July 23rd, 2002

Authors of a research letter in the Lancet report how the introduction of a recent vaccination campaign in the U.K. has substantially reduced the potential for group C meningococcal infection among children.

In the absence of effective vaccination programs, meningococcal disease remains a major public health problem worldwide. In Europe, North America, and Australasia most cases occur in young children and adolescents and are caused by group B or C meningococcal bacteria. The U.K. was the first country to introduce vaccination against meningococcal group C disease in November 1999. The entire population age 18 years or younger - around 14 million people - were...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2002-07-23)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry